Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Better Therapeutics Inc (NQ: BTTX )

0.3660 +0.0216 (+6.27%)
Streaming Delayed Price Updated: 3:59 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 515,258
Open 0.3701
Bid (Size) 0.3700 (10)
Ask (Size) 0.3850 (20)
Prev. Close 0.3444
Today's Range 0.3660 - 0.4300
52wk Range 0.3226 - 1.860
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Blue Apron Holdings, Inc. (NASDAQ: APRN) climbed 133.5% to $12.82 after the company announced an agreement to be acquired by Wonder Group for $13 per share. 
Via Benzinga
Why Glimpse Group Shares Are Trading Lower By Around 41%; Here Are 20 Stocks Moving Premarket
Gainers RVL Pharmaceuticals plc (NASDAQ: RVLP) shares rose 181.8% to $0.2201 in pre-market trading. 
Via Benzinga

Performance

YTD
-66.73%
-66.73%
1 Month
-40.98%
-40.98%
3 Month
-69.75%
-69.75%
6 Month
-48.60%
-48.60%
1 Year
-79.20%
-79.20%

More News

Read More
Better Therapeutics: Q1 Earnings Insights
Via Benzinga
Better Therapeutics Completes Enrollment in Real-World Evidence Program Evaluating Long-term Effectiveness of AspyreRx in Type 2 Diabetes
From Better Therapeutics, Inc.
Via Business Wire
Diabetes Prevalence Continues To Rise – Better Therapeutics' Digital Treatment Could Help Change This Trajectory
Via Benzinga
Why Rubicon Technologies Shares Are Trading Lower By Over 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Better Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics to Release Second Quarter 2023 Financial Results and Provide Business Update on August 09, 2023
From Better Therapeutics, Inc.
Via Business Wire
Why Rover Group Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Better Therapeutics Announces $6.7 Million in New Financing at an Average Price of $0.77 per Share
From Better Therapeutics, Inc.
Via Business Wire
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Crude Oil Rises 2%; ADC Therapeutics Shares Plummet
Via Benzinga
Dow Jumps Over 100 Points; US Small Business Optimism Index Tops Estimates
Via Benzinga
Why Are Better Therapeutics Shares Gaining Today?
Via Benzinga
Why Is Iovance Biotherapeutics (IOVA) Stock Down 10% Today?
Via InvestorPlace
Why Is EzFill (EZFL) Stock Down 5% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Is Better Therapeutics (BTTX) Stock Up 39% Today?
Via InvestorPlace
Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Better Therapeutics Receives FDA Authorization for AspyreRx™ to Treat Adults with Type 2 Diabetes
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics Announces Upcoming Poster Presentation at EASL Congress 2023 in Vienna, Austria
From Better Therapeutics, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.